Top Markets
#1 Black Phoenix Black Phoenix +736.90%
#2 Beam Beam +33.24%
#3 SAFEcoin SAFEcoin +19.80%
#4 THORChain THORChain +18.13%
#5 TENDIES TENDIES +18.02%
#6 Tutorial Tutorial +14.96%
#7 EfficientFrontier EfficientFrontier +14.67%
#8 Bless Bless +14.24%
#9 THORChain Yield THORChain Yield +13.45%
#10 Versatize Coin Versatize Coin +12.49%
Coin of the day
Black Phoenix Black Phoenix
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Pharvaris N.V. Pharvaris N.V.

Pharvaris N.V.

PHVS
Rangering i aksjer #5575
Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the... Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist to treat attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), which is in phase 3, as well as in phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.
Aksjekurs
$36.98
Sist synkronisert: 2026-08-26
Markedsverdi
$2.58B
Endring (1 dag)
-0.67%
Endring (1 år)
55.51%
Land
NL
Handel Pharvaris N.V. (PHVS)

Kategori

Healthcare
Aksjeprishistorikk for Pharvaris N.V. (PHVS)
Høyeste sluttskurs: $35.74 den 2026-08-01

Laveste sluttskurs: $31.41 den 2021-02-01
Aksjeprishistorikk for Pharvaris N.V. fra 2021 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 9.05%
2025 33.94%
2024 -24.64%
2023 230.41%
2022 -49.99%
2021 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $549.38 41.20%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 47.75%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $148.35 491.02%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.63 -12.65%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $763.43 6.94%
CH